Medical devices, healthcare technology and the business of care
510(k) clearance · K260906

a2z-Abdo-Triage

A2z Radiology Ai, Inc. · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK260906

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for a2z-Abdo-Triage, a traditional 510(k) submitted by A2z Radiology Ai, Inc. of Boston under K260906. The device is radiological computer-aided triage and notification software (21 CFR 892.2080, Class II, product codes QAS and QFM) that analyzes abdominopelvic CT images in adults aged 22 and older and flags suspected cases among ten listed findings. The summary names a2z-Unified-Triage (K252366) as predicate and states no reference devices were used. SESE is a clearance, not a PMA approval.

The summary describes cloud-based and on-premises deployment and a Predetermined Change Control Plan, which the database lists as authorized. Standalone performance figures appear for some findings at biased and balanced operating points; the source does not give a full performance table, and no independent clinical or comparative claims are supported here.

The database lists a March 19, 2026 receipt date, while the clearance letter states the application was dated August 13, 2026 and received August 14, 2026; the discrepancy is unresolved in the provided material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260906
Regulatory pathway
510(k) premarket notification
Product code
QAS
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Radiological Computer-Assisted Triage And Notification Software.

Product code
QAS
FDA device class
2

FDA decision timeline

  1. K260906 received

    Application receipt date recorded by FDA.

  2. K260906 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QAS

Product / regulatory recordCompanyPathwayDecision dateSource
Ever Fortune.Ai, Co., Ltd.510(k) clearanceOct 30, 2026FDA
Ischemaview, Inc.510(k) clearanceOct 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

A2z Radiology Ai, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Boston, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records